Book Description
The burgeoning interest in benign esophageal disease has developed due to several contributing factors: the emergence of focused interest in an ever-expanding knowledge base of general surgery, the availability of modern technology that allows testing of foregut function in an ambulatory office setting, and the reduced morbidity and greater patient acceptance of surgical therapy through limited access technology. The result of this interest has been the development of a new brand of modern surgeon characterized as having a disease focus as opposed to a focus on procedure. These new surgeons understand and are skilled in the diagnosis of disease by the measurement of altered organ function rather than by the presence of an anatomical lesion. They apply surgical therapy to improve the function of an organ by altering its structure or the arrangement of its moving parts rather than extirpation of the organ. Being talented open surgeons, they have become adept in the use of the new tools of limited access surgery. The common thread that links all of the contributors in this book is that they have passed through the laboratories or clinical services of the editors to learn the skills that have earned them the distinction of being a member of this new group of modern surgeons. The focus of this book is the physiologic approach to the understanding and management of esophageal disease. This is coupled with the utilization of minimally invasive thoracoscopic and laparoscopic surgery as a first option in the treatment of gastroesophageal reflux disease, esophageal motility disorders, esophageal diverticula, and benign esophageal tumours. Open surgery is reserved for the initial approach to complicated esophageal disease, reoperation of previously failed procedures, or esophageal replacement for end-stage benign disease. As such, the contributions report the present status of a changing approach to the exciting field of esophageal surgery.